ViGenCell Statistics

Total Valuation

ViGenCell has a market cap or net worth of KRW 60.32 billion. The enterprise value is 23.03 billion.

Market Cap	60.32B
Enterprise Value	23.03B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ViGenCell has 20.45 million shares outstanding. The number of shares has increased by 1.14% in one year.

Current Share Class	20.45M
Shares Outstanding	20.45M
Shares Change (YoY)	+1.14%
Shares Change (QoQ)	+1.28%
Owned by Insiders (%)	11.89%
Owned by Institutions (%)	3.82%
Float	13.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	216.26
PB Ratio	1.06
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.83
EV / Sales	82.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.54

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.14.

Current Ratio	5.77
Quick Ratio	5.73
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.85
Interest Coverage	-37.45

Financial Efficiency

Return on equity (ROE) is -20.23% and return on invested capital (ROIC) is -12.17%.

Return on Equity (ROE)	-20.23%
Return on Assets (ROA)	-11.91%
Return on Invested Capital (ROIC)	-12.17%
Return on Capital Employed (ROCE)	-23.36%
Revenue Per Employee	4.36M
Profits Per Employee	-196.23M
Employee Count	64
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.41% in the last 52 weeks. The beta is 1.10, so ViGenCell's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	-22.41%
50-Day Moving Average	3,032.20
200-Day Moving Average	3,061.43
Relative Strength Index (RSI)	46.71
Average Volume (20 Days)	33,418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViGenCell had revenue of KRW 278.95 million and -12.56 billion in losses. Loss per share was -650.72.

Revenue	278.95M
Gross Profit	4.30M
Operating Income	-13.56B
Pretax Income	-12.56B
Net Income	-12.56B
EBITDA	-10.23B
EBIT	-13.56B
Loss Per Share	-650.72

Full Income Statement

Balance Sheet

The company has 45.02 billion in cash and 7.72 billion in debt, giving a net cash position of 37.29 billion or 1,823.64 per share.

Cash & Cash Equivalents	45.02B
Total Debt	7.72B
Net Cash	37.29B
Net Cash Per Share	1,823.64
Equity (Book Value)	56.72B
Book Value Per Share	2,790.82
Working Capital	37.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.98 billion and capital expenditures -100.04 million, giving a free cash flow of -9.08 billion.

Operating Cash Flow	-8.98B
Capital Expenditures	-100.04M
Free Cash Flow	-9.08B
FCF Per Share	-444.10

Full Cash Flow Statement

Margins

Gross Margin	1.54%
Operating Margin	-4,861.71%
Pretax Margin	-4,502.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ViGenCell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.14%
Shareholder Yield	n/a
Earnings Yield	-20.82%
FCF Yield	-15.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jun 8, 2022
Split Type	Forward
Split Ratio	2

Scores

ViGenCell has an Altman Z-Score of 2.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	1